Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2001 1
2003 2
2004 1
2005 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean imbe h[au] (54 results)?
Discovery of novel and selective IKK-beta serine-threonine protein kinase inhibitors. Part 1.
Murata T, Shimada M, Sakakibara S, Yoshino T, Kadono H, Masuda T, Shimazaki M, Shintani T, Fuchikami K, Sakai K, Inbe H, Takeshita K, Niki T, Umeda M, Bacon KB, Ziegelbauer KB, Lowinger TB. Murata T, et al. Among authors: inbe h. Bioorg Med Chem Lett. 2003 Mar 10;13(5):913-8. doi: 10.1016/s0960-894x(02)01046-6. Bioorg Med Chem Lett. 2003. PMID: 12617920
A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity.
Ziegelbauer K, Gantner F, Lukacs NW, Berlin A, Fuchikami K, Niki T, Sakai K, Inbe H, Takeshita K, Ishimori M, Komura H, Murata T, Lowinger T, Bacon KB. Ziegelbauer K, et al. Among authors: inbe h. Br J Pharmacol. 2005 May;145(2):178-92. doi: 10.1038/sj.bjp.0706176. Br J Pharmacol. 2005. PMID: 15753951 Free PMC article.
Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats.
Shichijo M, Sugimoto H, Nagao K, Inbe H, Encinas JA, Takeshita K, Bacon KB, Gantner F. Shichijo M, et al. Among authors: inbe h. J Pharmacol Exp Ther. 2003 Nov;307(2):518-25. doi: 10.1124/jpet.103.055442. Epub 2003 Sep 15. J Pharmacol Exp Ther. 2003. PMID: 12975488